US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Instil Bio, Inc.

16.00

+0.54503.53%

Post-market: 16.000.00000.00%16:05 EDT

Volume:40.17K

Turnover:632.27K

Market Cap:104.41M

PE:-1.40

High:16.22

Open:15.12

Low:15.12

Close:15.46

Loading ...

Overview Company News Filings

Is Iovance Biotherapeutics (IOVA) the Most Promising Penny Stock According to Analysts?

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Is Iovance Biotherapeutics Inc. (NASDAQ:IOVA) the Best Biotech Penny Stock to Buy According to Hedge Funds?

Here's Why Summit Therapeutics Stock Soared 15% on Friday

Perspective Therapeutics Announces First Patient Dosed with [212Pb]VMT01 Monotherapy at 1.5 mCi in a Phase 1/2a Study of MC1R-Positive Metastatic Melanoma

TIL Enviro Full Year 2024 Earnings: EPS: HK$0.066 (vs HK$0.073 in FY 2023)

Simply Wall St.

Press Release: Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results

Till Capital Addresses Tax Reporting Error on Capital Distribution

Mamata Machinery Ltd. Strengthens Investor Relations and Compliance

Perspective Therapeutics Announces First Patient Dosed with [212Pb]VMT01 in Combination with Nivolumab in a Phase 1/2a Study of MC1R-Positive Metastatic Melanoma

Instil Bio Price Target Maintained With a $110.00/Share by HC Wainwright & Co.

Instil Bio’s Promising Pipeline and Strategic Collaborations Drive Buy Rating

JMP Securities Keeps Their Hold Rating on Instil Bio (TIL)

Instil Bio reports Q4 adjusted EPS ($1.08) vs. ($1.26) last year

Instil Bio Q4 2024 GAAP EPS $(1.82) Beats $(3.22) Estimate, Instil Had $115.1M In Total Cash, Cash Equivalents, Restricted Cash And Marketable Securities, That Is Expected To Fund Its Current Operating Plan Beyond 2026

BRIEF-Instil Bio Q4 Basic EPS USD -1.82

Instil Bio Q4 Basic EPS USD -1.82

THOMSON REUTERS

Instil Bio Inc - Expects Cash to Fund Operations Beyond 2026

THOMSON REUTERS

Press Release: Instil Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Fourth Quarter and Full Year 2024

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/TIL/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TIL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TIL\",,,,,undefined,":{"symbol":"TIL","market":"US","secType":"STK","nameCN":"Instil Bio, Inc.","latestPrice":16,"timestamp":1745265600000,"preClose":15.455,"halted":0,"volume":40174,"hourTrading":{"tag":"盘后","latestPrice":16,"preClose":16,"latestTime":"16:05 EDT","volume":62,"amount":992,"timestamp":1745265913471},"delay":0,"floatShares":2669983,"shares":6525887,"eps":-11.39,"marketStatus":"Not Yet Opened","change":0.545,"latestTime":"04-21 16:00:00 EDT","open":15.12,"high":16.215,"low":15.12,"amount":632265.8485,"amplitude":0.070851,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-11.39,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745308800000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1616126400000,"exchange":"NASDAQ","adjPreClose":15.455,"postHourTrading":{"tag":"盘后","latestPrice":16,"preClose":16,"latestTime":"16:05 EDT","volume":62,"amount":992,"timestamp":1745265913471},"volumeRatio":0.560457,"impliedVol":5.6162,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TIL\",,,,,undefined,":{"symbol":"TIL","floatShares":2669983,"roa":"-12.72%","roe":"-37.51%","lyrEps":-11.387623,"volumeRatio":0.560457,"shares":6525887,"dividePrice":0,"high":16.215,"amplitude":0.070851,"preClose":15.455,"low":15.12,"week52Low":9.62,"pbRate":"0.62","week52High":92,"institutionHeld":0,"latestPrice":16,"eps":-11.39,"divideRate":0,"volume":40174,"delay":0,"ttmEps":-11.39,"open":15.12,"prevYearClose":19.09,"prevWeekClose":15.455,"prevMonthClose":17.36,"prevQuarterClose":17.36,"fiveDayClose":15.03,"twentyDayClose":17.89,"sixtyDayClose":24.13},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TIL\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2528701745","title":"Is Iovance Biotherapeutics (IOVA) the Most Promising Penny Stock According to Analysts?","url":"https://stock-news.laohu8.com/highlight/detail?id=2528701745","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528701745?lang=en_us&edition=fundamental","pubTime":"2025-04-19 05:44","pubTimestamp":1745012681,"startTime":"0","endTime":"0","summary":"We recently published a list of the 11 Most Promising Penny Stocks According to Analysts. In this article, we are going to take a look at where Iovance Biotherapeutics, Inc.  stands against other promising penny stocks.Why are we interested in the stocks that hedge funds pile into?The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage poi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/iovance-biotherapeutics-iova-most-promising-214441921.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IOVA","TIL",".IXIC","NQmain","BK4505","SQQQ","USAW.SI","QLD","NVIW.SI","TSYW.SI","USJW.SI","PSQ","TQQQ","MNQmain","QID","BK4139"],"gpt_icon":1},{"id":"2528012471","title":"Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2528012471","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528012471?lang=en_us&edition=fundamental","pubTime":"2025-04-19 05:30","pubTimestamp":1745011800,"startTime":"0","endTime":"0","summary":"SAN CARLOS, Calif., April 18, 2025  -- Iovance Biotherapeutics, Inc.  , a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte  therapies for patients with cancer, today announced that on April 17, 2025 , the Company approved the grant of inducement stock options covering an aggregate of 297,600 shares of Iovance’s common stock to fifty new, non-executive employees.Iovance Biotherapeutics, Inc. aims to be the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte  therapies for patients with cancer. We are pioneering a transformational approach to cure cancer by harnessing the human immune system’s ability to recognize and destroy diverse cancer cells in each patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors. Iovance’s Amtagvi is the first FDA-approved T cell therapy for a solid tumor indication. We are committed to continuous innovation","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/iovance-biotherapeutics-reports-inducement-grants-213000213.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TIL","BK4139","BK4505","PSQ","MNQmain","LU2095319765.USD","TQQQ","NDAQ","SQQQ","QLD","BK4585","LU2210149790.SGD","TSYW.SI","BK4588","IE00BGHQF748.EUR","IOVA","LU2210150020.SGD","USJW.SI","IE00BKPKM429.USD","BK4112","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","NQmain","USAW.SI",".IXIC","QID","NVIW.SI"],"gpt_icon":1},{"id":"2528847220","title":"Is Iovance Biotherapeutics Inc. (NASDAQ:IOVA) the Best Biotech Penny Stock to Buy According to Hedge Funds?","url":"https://stock-news.laohu8.com/highlight/detail?id=2528847220","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528847220?lang=en_us&edition=fundamental","pubTime":"2025-04-16 22:02","pubTimestamp":1744812158,"startTime":"0","endTime":"0","summary":"We recently published a list of the 13 Best Biotech Penny Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Iovance Biotherapeutics Inc.  stands against other biotech penny stocks.Peter Marks’s departure from the FDA has left innovators concerned regarding the current state of the review program at the FDA. Marks had impacts on two key areas. First the vaccine approvals and the subsequent resurgence of new vaccines over the past two decades, and then the establishment of the cell and gene therapy field that he’s credited for. He was involved in developing policies aimed at optimizing the process of bringing several innovative products to the market. Following his resignation, a substantial number of other departures are also anticipated, which implies upcoming destabilization at the FDA for its existing expertise and processes.We sifted through ETFs, stock screeners, and financial media reports to compile a list of the top biotech penny stock","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/iovance-biotherapeutics-inc-nasdaq-iova-140238275.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B3QW5Z07.USD","USAW.SI","NDAQ","TQQQ","MNQmain","NQmain","BK4505","BK4585","BK4112","USJW.SI","QID","IOVA",".IXIC","LU2210149790.SGD","QLD","BK4588","TSYW.SI","PSQ","NVIW.SI","BK4139","LU2095319765.USD","LU2210150020.SGD","TIL","SQQQ","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00BKPKM429.USD"],"gpt_icon":1},{"id":"2527276154","title":"Here's Why Summit Therapeutics Stock Soared 15% on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=2527276154","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527276154?lang=en_us&edition=fundamental","pubTime":"2025-04-14 17:57","pubTimestamp":1744624620,"startTime":"0","endTime":"0","summary":"Shares of Summit Therapeutics SMMT rose more than 15% on Friday after the analysts at Cantor Fitzgerald and Truist Securities maintained their positive outlook on the company.Both investment firms remain optimistic about Summit Therapeutics’ lead pipeline drug, ivonescimab. This drug was developed in collaboration with China-based Akeso, which is also its original developer. Summit in-licensed the right to develop and market the drug in 2022 across several territories, including the United States and Europe.Cantor reportedly reiterated its Overweight rating on SMMT after an SEC filing revealed that the company’s co-chief executive officer , Bob Duggan, exercised warrants to acquire nearly 4 million shares of the company. This transaction was executed about four years before the warrants expired at a strike price of $1.58 each. The analyst pointed out that this indicated a bullish signal for the stock.Another regulatory filing also revealed that the company’s other co-CEO, Zanganeh Mahk","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heres-why-summit-therapeutics-stock-095700433.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LENZ","BK4195","LU1069347547.HKD","BNTX","BK4559","SG9999014559.SGD","SMMT","LU1093756325.SGD","LU0211331839.USD","LU2106854487.HKD","LU0289739699.SGD","SG9999015341.SGD","BK4568","LU1066051498.USD","IE00BN8TJ469.HKD","LU0070302665.USD","LU1929549753.HKD","LU1093756168.USD","LU2468319806.SGD","IE00BLSP4239.USD","LU0265550359.USD","TIL","LU1989772840.SGD","IE00BLSP4452.SGD","LU1162221912.USD","LU0265550946.USD","LU0266013472.USD","LU2361044949.HKD","LU1291159041.SGD","LU2324357040.USD","LU1941712348.USD","LU0965508806.USD","IE00BFTCPJ56.SGD","LU1571399168.USD","LU1934455194.USD","LU0320765646.SGD","LU1974910355.USD","OS","PFS","IE00BJJMRZ35.SGD","MRK","IE00B1BXHZ80.USD","LU1116320737.USD","LU1066051811.HKD","LU2488822045.USD","LU0965509283.SGD","LU0965509101.SGD","SMMF","LU0203345920.USD","LU0203347892.USD"],"gpt_icon":1},{"id":"2526652177","title":"Perspective Therapeutics Announces First Patient Dosed with [212Pb]VMT01 Monotherapy at 1.5 mCi in a Phase 1/2a Study of MC1R-Positive Metastatic Melanoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2526652177","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526652177?lang=en_us&edition=fundamental","pubTime":"2025-04-11 19:00","pubTimestamp":1744369200,"startTime":"0","endTime":"0","summary":"Patients in this cohort are receiving [212Pb]VMT01 at 1.5 mCi as monotherapy. Initial results from the earlier monotherapy cohorts were previously presented at the 21st International Congress of the Society for Melanoma Research  in October 2024. A cohort administering a combination regimen with the immune checkpoint inhibitor nivolumab commenced dosing in March 2025.\"This further dose finding of [212Pb]VMT01 as monotherapy in patients with metastatic melanoma follows the encouraging initial monotherapy results from our Phase 1/2a study,\" commented Markus Puhlmann, Chief Medical Officer of Perspective. \"This cohort allows enrollment of patients whose disease has spread to their brain, which is a common site of metastases and may add symptom burden for these patients. Previously generated images by an independent collaborator using [203Pb]VMT01 and [68Ga]VMT02 show tracer uptake by brain metastases which warrant exploring the therapeutic utility of [212Pb]VMT01 in these patients.\". Abou","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/perspective-therapeutics-announces-first-patient-110000800.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4505","SMR","BK4606","CATX","BK4182","TIL","TAT","BK4139"],"gpt_icon":0},{"id":"2523662618","title":"TIL Enviro Full Year 2024 Earnings: EPS: HK$0.066 (vs HK$0.073 in FY 2023)","url":"https://stock-news.laohu8.com/highlight/detail?id=2523662618","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523662618?lang=en_us&edition=fundamental","pubTime":"2025-03-29 09:16","pubTimestamp":1743211010,"startTime":"0","endTime":"0","summary":"TIL Enviro ( HKG:1790 ) Full Year 2024 Results Key Financial Results Revenue: HK$230.6m (up 28% from FY 2023). Net...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/3114000-choice1-main-header/1585186850497","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3114000-choice1-main-header/1585186850497"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/commercial-services/hkg-1790/til-enviro-shares/news/til-enviro-full-year-2024-earnings-eps-hk0066-vs-hk0073-in-f","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TIL","01790"],"gpt_icon":0},{"id":"2523265560","title":"Press Release: Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2523265560","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523265560?lang=en_us&edition=fundamental","pubTime":"2025-03-29 09:03","pubTimestamp":1743210180,"startTime":"0","endTime":"0","summary":"SAN DIEGO, March 28, 2025  -- Turnstone Biologics Corp.  , a biotechnology company historically focused on the development of a differentiated approach to treat and cure patients with solid tumors by pioneering selected tumor-infiltrating lymphocyte  therapy, today announced its financial results for the fourth quarter and full year ended December 31, 2024, and provided recent corporate updates.In November 2024, the Company presented preclinical data on its Selected TIL therapies at the 2024 Society for Immunotherapy of Cancer  Annual Meeting. Turnstone also presented clinical data at the SITC TIL Symposium in a presentation titled \"TIDAL-01: Enriching for a More Potent TIL Population with Selected TIL Therapy\".Statements contained in this press release regarding matters that may occur in the future are \"forward looking statements\" within the meaning of the Private Securities Litigation Reform Act of 1995, including but not limited to statemen","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TIL","BK4139","BK4505","TSBX"],"gpt_icon":0},{"id":"2523636251","title":"Till Capital Addresses Tax Reporting Error on Capital Distribution","url":"https://stock-news.laohu8.com/highlight/detail?id=2523636251","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523636251?lang=en_us&edition=fundamental","pubTime":"2025-03-29 05:10","pubTimestamp":1743196222,"startTime":"0","endTime":"0","summary":"Till Capital ( ($TSE:TIL) ) has provided an update. Till Capital Corporation has alerted its shareholders about an incorrect reporting of its April...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/till-capital-addresses-tax-reporting-error-on-capital-distribution?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/till-capital-addresses-tax-reporting-error-on-capital-distribution?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TIL","BK4505","BK4139"],"gpt_icon":0},{"id":"2521223101","title":"Mamata Machinery Ltd. Strengthens Investor Relations and Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2521223101","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521223101?lang=en_us&edition=fundamental","pubTime":"2025-03-23 08:12","pubTimestamp":1742688745,"startTime":"0","endTime":"0","summary":"Mamata Machinery Ltd. ( ($IN:MAMATA) ) just unveiled an announcement. Mamata Machinery Limited has announced the appointment of TIL Advisors Privat...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mamata-machinery-ltd-strengthens-investor-relations-and-compliance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mamata-machinery-ltd-strengthens-investor-relations-and-compliance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TIL","BK4505","BK4139"],"gpt_icon":0},{"id":"2520541445","title":"Perspective Therapeutics Announces First Patient Dosed with [212Pb]VMT01 in Combination with Nivolumab in a Phase 1/2a Study of MC1R-Positive Metastatic Melanoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2520541445","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520541445?lang=en_us&edition=fundamental","pubTime":"2025-03-17 19:00","pubTimestamp":1742209200,"startTime":"0","endTime":"0","summary":"Patients in this cohort are receiving [212Pb]VMT01 at 1.5 mCi in combination with nivolumab, a PD-1 blocking antibody developed and marketed by Bristol Myers Squibb as Opdivo. Patients in earlier cohorts received [212Pb]VMT01 as monotherapy. Initial results from the earlier cohorts were previously presented at the 21st International Congress of the Society for Melanoma Research  in October 2024.About [212Pb]VMT01Perspective designed [212Pb]VMT01 to target and deliver 212Pb to tumor sites expressing MC1R, a protein that can be overexpressed in metastatic melanoma tumors.1 The Company is conducting a multi-center, open-label dose escalation, dose expansion study  in patients with histologically confirmed melanoma and MC1R-positive imaging scans. In September 2024, the Company announced that the U.S. Food and Drug Administration  granted Fast Track Designation for the development of [212Pb]VMT01 for the diagnosis and treatment of patients with unresectable or metastatic melanoma and who h","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/perspective-therapeutics-announces-first-patient-110000400.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CATX","BK4139","TIL","BK4182","TAT","BK4606","SMR","BK4505"],"gpt_icon":0},{"id":"2517713915","title":"Instil Bio Price Target Maintained With a $110.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2517713915","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517713915?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:22","pubTimestamp":1741177320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TIL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 05, 2025 07:22 ET (12:22 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TIL"],"gpt_icon":0},{"id":"2517918604","title":"Instil Bio’s Promising Pipeline and Strategic Collaborations Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2517918604","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517918604?lang=en_us&edition=fundamental","pubTime":"2025-03-05 19:39","pubTimestamp":1741174779,"startTime":"0","endTime":"0","summary":"Analyst Mitchell Kapoor from H.C. Wainwright reiterated a Buy rating on Instil Bio (TIL – Research Report) and keeping the price target at $110.00....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/instil-bios-promising-pipeline-and-strategic-collaborations-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/instil-bios-promising-pipeline-and-strategic-collaborations-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TIL"],"gpt_icon":0},{"id":"2517600767","title":"JMP Securities Keeps Their Hold Rating on Instil Bio (TIL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517600767","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517600767?lang=en_us&edition=fundamental","pubTime":"2025-03-05 02:26","pubTimestamp":1741112760,"startTime":"0","endTime":"0","summary":"JMP Securities analyst Reni Benjamin reiterated a Hold rating on Instil Bio (TIL – Research Report) today. The company’s shares opened today at $18...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jmp-securities-keeps-their-hold-rating-on-instil-bio-til-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jmp-securities-keeps-their-hold-rating-on-instil-bio-til-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JMP","TIL"],"gpt_icon":0},{"id":"2516673356","title":"Instil Bio reports Q4 adjusted EPS ($1.08) vs. ($1.26) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2516673356","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516673356?lang=en_us&edition=fundamental","pubTime":"2025-03-04 20:18","pubTimestamp":1741090700,"startTime":"0","endTime":"0","summary":"As of December 31, 2024, Instil had $115.1 million in total cash, cash equivalents, restricted cash and marketable securities, which consisted of $...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/instil-bio-reports-q4-adjusted-eps-1-08-vs-1-26-last-year?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/instil-bio-reports-q4-adjusted-eps-1-08-vs-1-26-last-year?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TIL"],"gpt_icon":0},{"id":"2516180678","title":"Instil Bio Q4 2024 GAAP EPS $(1.82) Beats $(3.22) Estimate, Instil Had $115.1M In Total Cash, Cash Equivalents, Restricted Cash And Marketable Securities, That Is Expected To Fund Its Current Operating Plan Beyond 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2516180678","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516180678?lang=en_us&edition=fundamental","pubTime":"2025-03-04 20:13","pubTimestamp":1741090390,"startTime":"0","endTime":"0","summary":"Instil Bio (NASDAQ:TIL) reported quarterly losses of $(1.82) per share which beat the analyst consensus estimate of $(3.22) by 43.48 percent. This is a 8.54 percent increase over losses of $(1.99) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44104858/instil-bio-q4-2024-gaap-eps-1-82-beats-3-22-estimate-instil-had-115-1m-in-total-cash-cash-equivalen","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TIL","TSS"],"gpt_icon":0},{"id":"2516678366","title":"BRIEF-Instil Bio Q4 Basic EPS USD -1.82","url":"https://stock-news.laohu8.com/highlight/detail?id=2516678366","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516678366?lang=en_us&edition=fundamental","pubTime":"2025-03-04 20:10","pubTimestamp":1741090211,"startTime":"0","endTime":"0","summary":"BRIEF-Instil Bio Q4 Basic EPS USD -1.82\n\n\nMar 04 (Reuters) - Instil Bio Q4 net income USD -11.895 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nPLXE51E4A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TIL"],"gpt_icon":0},{"id":"2516467835","title":"Instil Bio Q4 Basic EPS USD -1.82","url":"https://stock-news.laohu8.com/highlight/detail?id=2516467835","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516467835?lang=en_us&edition=fundamental","pubTime":"2025-03-04 20:09","pubTimestamp":1741090166,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nPLXE51E4A:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","BK4139","TIL"],"gpt_icon":0},{"id":"2516309678","title":"Instil Bio Inc - Expects Cash to Fund Operations Beyond 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2516309678","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516309678?lang=en_us&edition=fundamental","pubTime":"2025-03-04 20:09","pubTimestamp":1741090166,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nPLXE51E4A:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TIL","BK4139","BK4505"],"gpt_icon":0},{"id":"2516789586","title":"Press Release: Instil Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2516789586","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516789586?lang=en_us&edition=fundamental","pubTime":"2025-03-04 20:09","pubTimestamp":1741090140,"startTime":"0","endTime":"0","summary":"Enrollment of 1L NSCLC patients in trial of AXN-2510/IMM2510 and chemotherapy by ImmuneOnco in China anticipated to begin in Q2 2025 with initial clinical data by ImmuneOnco expected in 2H 2025. Initiation of U.S. clinical study of AXN-2510/IMM2510 in combination with chemotherapy in 1L NSCLC anticipated before the end of 2025, assuming receipt of necessary regulatory approvals. DALLAS, March 04, 2025  -- Instil Bio, Inc.  , a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies, today reported its fourth quarter and full year 2024 financial results and provided a corporate update.-- Clinical data for AXN-2510  /IMM2510 anticipated in 1H. clinical data update for AXN-2510/IMM2510 monotherapy in relapsed or. of 2025. Instil anticipates that ImmuneOnco will also release safety data. As of December 31, 2024, Instil had $115.1 million in total cash, cash equivalents, restricted cash and marketable securities, which consisted of $8.8 million in cash a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TIL"],"gpt_icon":0},{"id":"2514559330","title":"Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Fourth Quarter and Full Year 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2514559330","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514559330?lang=en_us&edition=fundamental","pubTime":"2025-02-28 05:01","pubTimestamp":1740690060,"startTime":"0","endTime":"0","summary":"Significant Demand for Amtagvi (Lifileucel) Continues with Total Product Revenue of $73.7M in 4Q24 and $164.1M in FY24, Achieving Upper End of FY24 Guidance Range of $160M-$165M Reaffirming FY25 Total","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/27/3034267/0/en/Iovance-Biotherapeutics-Reports-Financial-Results-and-Corporate-Updates-for-Fourth-Quarter-and-Full-Year-2024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","MAA","TIL","BK4215","BK4505","BK4139","IOVA","BK4585"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":75,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TIL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-04","symbol":"TIL","fiscalQuarterEnding":"2024/12","expectedEps":-3.75,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741064400000,"reportTimeType":"pre","actualEps":-1.82},{"market":"US","date":"2024-11-13","symbol":"TIL","fiscalQuarterEnding":"2024/09","expectedEps":-2.08,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":-3.54},{"market":"US","date":"2024-08-13","symbol":"TIL","fiscalQuarterEnding":"2024/06","expectedEps":-3.04,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"post","actualEps":-2.29},{"market":"US","date":"2024-05-10","symbol":"TIL","fiscalQuarterEnding":"2024/03","expectedEps":-2.16,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715313600000,"reportTimeType":"pre","actualEps":-3.74},{"market":"US","date":"2024-03-21","symbol":"TIL","fiscalQuarterEnding":"2023/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1710993600000,"reportTimeType":"post","actualEps":-1.99}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TIL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TIL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.25,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.25,"analysts":4,"updateTime":1736222400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TIL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TIL","date":"2025-04-17","current":-1.346814,"percent":0.560319,"low":-90.213566,"twenty":-17.417162,"median":-1.749709,"eighty":-0.373783,"high":-0.20845,"avg":-9.866033,"sd":17.226693,"marketCap":99846071},"quantilePoints":[{"date":"2021-03-19","current":-84.27082,"twenty":-76.060471,"median":-63.744947,"eighty":-63.744947,"marketCap":3180212216},{"date":"2021-03-26","current":-90.213566,"twenty":-88.546649,"median":-82.774855,"eighty":-70.558494,"marketCap":3404479566},{"date":"2021-04-01","current":-80.485142,"twenty":-88.066577,"median":-82.445731,"eighty":-80.543876,"marketCap":3037348273},{"date":"2021-04-09","current":-74.845406,"twenty":-86.731338,"median":-81.278889,"eighty":-75.844251,"marketCap":2824515933},{"date":"2021-04-16","current":-64.55119,"twenty":-84.152401,"median":-80.631978,"eighty":-68.532979,"marketCap":2436032807},{"date":"2021-04-23","current":-56.533253,"twenty":-83.665496,"median":-75.558867,"eighty":-63.744947,"marketCap":2133451889},{"date":"2021-04-30","current":-69.749259,"twenty":-83.442343,"median":-72.705025,"eighty":-62.947602,"marketCap":2632197554},{"date":"2021-05-07","current":-64.381318,"twenty":-82.464914,"median":-70.870412,"eighty":-62.947602,"marketCap":2429622194},{"date":"2021-05-14","current":-40.815404,"twenty":-81.185542,"median":-68.797979,"eighty":-59.923889,"marketCap":2317376214},{"date":"2021-05-21","current":-41.745089,"twenty":-80.805485,"median":-64.55119,"eighty":-56.641971,"marketCap":2370160894},{"date":"2021-05-28","current":-40.3619,"twenty":-80.72008,"median":-63.825313,"eighty":-44.35274,"marketCap":2291627589},{"date":"2021-06-04","current":-35.28265,"twenty":-80.485142,"median":-63.604479,"eighty":-40.88343,"marketCap":2003242993},{"date":"2021-06-11","current":-38.547882,"twenty":-76.985788,"median":-62.478757,"eighty":-39.182788,"marketCap":2188633091},{"date":"2021-06-18","current":-40.860755,"twenty":-75.558867,"median":-60.066581,"eighty":-39.182788,"marketCap":2319951076},{"date":"2021-06-25","current":-43.082927,"twenty":-74.845406,"median":-57.586456,"eighty":-39.454891,"marketCap":2446119337},{"date":"2021-07-02","current":-45.531851,"twenty":-74.539637,"median":-55.870754,"eighty":-40.135148,"marketCap":2585161909},{"date":"2021-07-09","current":-45.305099,"twenty":-72.202205,"median":-49.175495,"eighty":-40.243989,"marketCap":2572287597},{"date":"2021-07-16","current":-42.856175,"twenty":-71.45477,"median":-45.531851,"eighty":-40.34376,"marketCap":2433245024},{"date":"2021-07-23","current":-44.035286,"twenty":-70.97913,"median":-45.259749,"eighty":-40.507022,"marketCap":2500191448},{"date":"2021-07-30","current":-34.126213,"twenty":-69.97349,"median":-44.352739,"eighty":-39.999097,"marketCap":1937584001},{"date":"2021-08-06","current":-38.797309,"twenty":-69.667721,"median":-44.114649,"eighty":-38.86987,"marketCap":2202794834},{"date":"2021-08-13","current":-25.67905,"twenty":-68.288364,"median":-43.967261,"eighty":-38.248569,"marketCap":2128433760},{"date":"2021-08-20","current":-25.958677,"twenty":-65.584009,"median":-43.842547,"eighty":-37.250859,"marketCap":2151610897},{"date":"2021-08-27","current":-31.054096,"twenty":-64.639523,"median":-43.082927,"eighty":-36.865381,"marketCap":2573949841},{"date":"2021-09-03","current":-33.368784,"twenty":-64.415292,"median":-42.810824,"eighty":-36.162449,"marketCap":2765805032},{"date":"2021-09-10","current":-29.003501,"twenty":-64.095934,"median":-42.300631,"eighty":-35.128458,"marketCap":2403984168},{"date":"2021-09-17","current":-30.696796,"twenty":-63.809239,"median":-41.745089,"eighty":-33.823241,"marketCap":2544334610},{"date":"2021-09-24","current":-35.869889,"twenty":-63.744947,"median":-41.200883,"eighty":-33.058088,"marketCap":2973111647},{"date":"2021-10-01","current":-29.702568,"twenty":-63.576386,"median":-40.88343,"eighty":-32.244063,"marketCap":2461927011},{"date":"2021-10-08","current":-27.884994,"twenty":-63.076705,"median":-40.679353,"eighty":-30.911176,"marketCap":2311275620},{"date":"2021-10-15","current":-27.83839,"twenty":-62.614654,"median":-40.271199,"eighty":-30.162398,"marketCap":2307412764},{"date":"2021-10-22","current":-28.288899,"twenty":-61.744912,"median":-39.31884,"eighty":-29.292448,"marketCap":2344753707},{"date":"2021-10-29","current":-31.644419,"twenty":-60.684913,"median":-38.88801,"eighty":-29.292448,"marketCap":2622879353},{"date":"2021-11-05","current":-33.928037,"twenty":-60.019017,"median":-38.547882,"eighty":-29.457117,"marketCap":2812159306},{"date":"2021-11-12","current":-32.125999,"twenty":-59.054147,"median":-38.230429,"eighty":-29.609358,"marketCap":2662795533},{"date":"2021-11-19","current":-24.170578,"twenty":-57.966968,"median":-37.380108,"eighty":-29.087389,"marketCap":2867331542},{"date":"2021-11-26","current":-22.13825,"twenty":-57.38261,"median":-37.142018,"eighty":-28.403857,"marketCap":2626238467},{"date":"2021-12-03","current":-21.670923,"twenty":-56.859406,"median":-36.892591,"eighty":-28.164621,"marketCap":2570799953},{"date":"2021-12-10","current":-21.616583,"twenty":-56.003254,"median":-36.597813,"eighty":-28.071412,"marketCap":2564353614},{"date":"2021-12-17","current":-17.443246,"twenty":-54.107487,"median":-36.165051,"eighty":-27.857032,"marketCap":2069274786},{"date":"2021-12-23","current":-17.53019,"twenty":-51.143999,"median":-35.869889,"eighty":-27.625563,"marketCap":2079588929},{"date":"2021-12-31","current":-18.595261,"twenty":-45.822094,"median":-35.259974,"eighty":-26.135774,"marketCap":2205937171},{"date":"2022-01-07","current":-15.628279,"twenty":-45.531851,"median":-34.953335,"eighty":-25.306214,"marketCap":1853967067},{"date":"2022-01-14","current":-15.052271,"twenty":-45.500106,"median":-34.640367,"eighty":-24.382747,"marketCap":1785635875},{"date":"2022-01-21","current":-13.802444,"twenty":-45.373125,"median":-34.027125,"eighty":-24.170578,"marketCap":1637370080},{"date":"2022-01-28","current":-11.889664,"twenty":-45.305099,"median":-33.539667,"eighty":-23.692383,"marketCap":1410458951},{"date":"2022-02-04","current":-12.509144,"twenty":-45.214398,"median":-33.399854,"eighty":-22.768598,"marketCap":1483947214},{"date":"2022-02-11","current":-12.976471,"twenty":-45.169048,"median":-33.368784,"eighty":-21.583979,"marketCap":1539385729},{"date":"2022-02-18","current":-11.552754,"twenty":-44.352739,"median":-32.545439,"eighty":-20.008109,"marketCap":1370491650},{"date":"2022-02-25","current":-11.737511,"twenty":-44.262038,"median":-32.273579,"eighty":-18.836532,"marketCap":1392409202},{"date":"2022-03-04","current":-9.368273,"twenty":-44.203083,"median":-31.644419,"eighty":-18.169232,"marketCap":1111348826},{"date":"2022-03-11","current":-8.15329,"twenty":-44.067031,"median":-31.256049,"eighty":-17.512801,"marketCap":1278386950},{"date":"2022-03-18","current":-9.248631,"twenty":-43.999006,"median":-30.696796,"eighty":-16.712911,"marketCap":1450129843},{"date":"2022-03-25","current":-9.141568,"twenty":-43.971796,"median":-30.409402,"eighty":-15.543508,"marketCap":1433342944},{"date":"2022-04-01","current":-9.186537,"twenty":-43.91284,"median":-29.842381,"eighty":-14.704493,"marketCap":1440393806},{"date":"2022-04-08","current":-7.761182,"twenty":-43.881095,"median":-29.601591,"eighty":-13.798097,"marketCap":1216906695},{"date":"2022-04-14","current":-7.596401,"twenty":-43.835744,"median":-29.290895,"eighty":-13.43945,"marketCap":1191070035},{"date":"2022-04-22","current":-6.920799,"twenty":-43.631667,"median":-29.003501,"eighty":-12.8917,"marketCap":1085139728},{"date":"2022-04-29","current":-5.825006,"twenty":-43.255259,"median":-28.420946,"eighty":-12.630866,"marketCap":913325938},{"date":"2022-05-06","current":-5.371858,"twenty":-42.946876,"median":-28.288899,"eighty":-12.27222,"marketCap":842275122},{"date":"2022-05-13","current":-5.207077,"twenty":-42.842569,"median":-28.164621,"eighty":-11.707081,"marketCap":816438462},{"date":"2022-05-20","current":-5.001319,"twenty":-42.806289,"median":-28.118016,"eighty":-11.233233,"marketCap":939162598},{"date":"2022-05-27","current":-4.127636,"twenty":-42.502441,"median":-27.985971,"eighty":-10.409434,"marketCap":775099806},{"date":"2022-06-03","current":-4.134515,"twenty":-42.302899,"median":-27.861692,"eighty":-9.489052,"marketCap":776391639},{"date":"2022-06-10","current":-3.769907,"twenty":-42.280224,"median":-27.768483,"eighty":-9.159556,"marketCap":707924489},{"date":"2022-06-17","current":-3.219556,"twenty":-42.058007,"median":-27.411182,"eighty":-8.948853,"marketCap":604577848},{"date":"2022-06-24","current":-3.51537,"twenty":-41.717879,"median":-26.401419,"eighty":-8.77169,"marketCap":660126668},{"date":"2022-07-01","current":-3.267712,"twenty":-41.545546,"median":-25.632446,"eighty":-8.355887,"marketCap":613620679},{"date":"2022-07-08","current":-4.058842,"twenty":-41.291584,"median":-25.244075,"eighty":-8.136819,"marketCap":762181475},{"date":"2022-07-15","current":-4.024445,"twenty":-41.110182,"median":-24.894542,"eighty":-7.761182,"marketCap":755722310},{"date":"2022-07-22","current":-4.141394,"twenty":-40.951456,"median":-24.246655,"eighty":-7.357468,"marketCap":777683472},{"date":"2022-07-29","current":-3.879978,"twenty":-40.88343,"median":-24.121672,"eighty":-6.983828,"marketCap":728593817},{"date":"2022-08-05","current":-4.389053,"twenty":-40.860755,"median":-23.779328,"eighty":-6.706584,"marketCap":824189460},{"date":"2022-08-12","current":-4.26255,"twenty":-40.815404,"median":-23.464154,"eighty":-6.039221,"marketCap":901375864},{"date":"2022-08-19","current":-3.495904,"twenty":-40.543302,"median":-22.768598,"eighty":-5.668464,"marketCap":739257903},{"date":"2022-08-26","current":-3.140181,"twenty":-40.3619,"median":-21.643753,"eighty":-5.371858,"marketCap":664035169},{"date":"2022-09-02","current":-3.213779,"twenty":-40.271199,"median":-21.529638,"eighty":-5.09997,"marketCap":679598493},{"date":"2022-09-09","current":-3.845495,"twenty":-40.162358,"median":-20.975367,"eighty":-4.903683,"marketCap":813183693},{"date":"2022-09-16","current":-3.207646,"twenty":-39.590942,"median":-19.404931,"eighty":-4.657349,"marketCap":678301549},{"date":"2022-09-23","current":-2.992985,"twenty":-39.237209,"median":-18.801754,"eighty":-4.457242,"marketCap":632908520},{"date":"2022-09-30","current":-2.968452,"twenty":-39.037666,"median":-18.220312,"eighty":-4.364287,"marketCap":627720745},{"date":"2022-10-07","current":-3.029784,"twenty":-38.910685,"median":-17.975781,"eighty":-4.243271,"marketCap":640690182},{"date":"2022-10-14","current":-2.741525,"twenty":-38.815449,"median":-17.486718,"eighty":-4.140018,"marketCap":579733829},{"date":"2022-10-21","current":-2.753791,"twenty":-38.597767,"median":-16.975919,"eighty":-4.113877,"marketCap":582327716},{"date":"2022-10-28","current":-3.219912,"twenty":-38.547882,"median":-16.641725,"eighty":-4.080856,"marketCap":680895437},{"date":"2022-11-04","current":-1.551691,"twenty":-38.31206,"median":-15.606543,"eighty":-4.029948,"marketCap":328126753},{"date":"2022-11-11","current":-1.386095,"twenty":-38.234964,"median":-15.084875,"eighty":-3.950163,"marketCap":293109273},{"date":"2022-11-18","current":-0.964579,"twenty":-38.030887,"median":-14.574076,"eighty":-3.838633,"marketCap":216724411},{"date":"2022-11-25","current":-0.808629,"twenty":-37.695294,"median":-13.835048,"eighty":-3.794075,"marketCap":181685135},{"date":"2022-12-02","current":-0.72199,"twenty":-37.355165,"median":-13.742669,"eighty":-3.696738,"marketCap":162218871},{"date":"2022-12-09","current":-0.553102,"twenty":-37.241789,"median":-13.269908,"eighty":-3.527753,"marketCap":124272632},{"date":"2022-12-16","current":-0.333213,"twenty":-37.123878,"median":-12.911262,"eighty":-3.465238,"marketCap":74867253},{"date":"2022-12-23","current":-0.288738,"twenty":-37.037712,"median":-12.759109,"eighty":-3.399796,"marketCap":64874570},{"date":"2022-12-30","current":-0.363883,"twenty":-36.974222,"median":-12.639561,"eighty":-3.322747,"marketCap":81758311},{"date":"2023-01-06","current":-0.36602,"twenty":-36.865381,"median":-12.617824,"eighty":-3.267965,"marketCap":82238478},{"date":"2023-01-13","current":-0.450695,"twenty":-36.752004,"median":-12.259179,"eighty":-3.250578,"marketCap":101263508},{"date":"2023-01-20","current":-0.43897,"twenty":-36.733864,"median":-11.82989,"eighty":-3.219912,"marketCap":98629073},{"date":"2023-01-27","current":-0.471604,"twenty":-36.461761,"median":-11.661435,"eighty":-3.213779,"marketCap":105961366},{"date":"2023-02-03","current":-0.514172,"twenty":-36.189659,"median":-11.308222,"eighty":-3.164521,"marketCap":115525791},{"date":"2023-02-10","current":-0.46063,"twenty":-36.165051,"median":-11.107163,"eighty":-3.066583,"marketCap":103495639},{"date":"2023-02-17","current":-0.465539,"twenty":-36.053607,"median":-10.384437,"eighty":-2.992985,"marketCap":104598728},{"date":"2023-02-24","current":-0.440818,"twenty":-35.906633,"median":-9.736518,"eighty":-2.973358,"marketCap":99044354},{"date":"2023-03-03","current":-0.444746,"twenty":-35.857462,"median":-9.368273,"eighty":-2.900034,"marketCap":99926824},{"date":"2023-03-10","current":-0.368157,"twenty":-35.396991,"median":-9.164053,"eighty":-2.835976,"marketCap":82718646},{"date":"2023-03-17","current":-0.369659,"twenty":-35.246369,"median":-9.062951,"eighty":-2.751338,"marketCap":83056062},{"date":"2023-03-24","current":-0.344245,"twenty":-35.019617,"median":-8.88809,"eighty":-2.66302,"marketCap":77345957},{"date":"2023-03-31","current":-0.384248,"twenty":-34.955707,"median":-8.762728,"eighty":-1.622836,"marketCap":85755384},{"date":"2023-04-06","current":-0.38474,"twenty":-34.810795,"median":-8.705078,"eighty":-1.551691,"marketCap":85865211},{"date":"2023-04-14","current":-0.381943,"twenty":-34.715769,"median":-8.253816,"eighty":-1.408174,"marketCap":85240832},{"date":"2023-04-21","current":-0.379087,"twenty":-34.625287,"median":-8.136819,"eighty":-1.09858,"marketCap":84603444},{"date":"2023-04-28","current":-0.36335,"twenty":-34.301714,"median":-7.897985,"eighty":-0.886026,"marketCap":81091309},{"date":"2023-05-05","current":-0.379436,"twenty":-34.007307,"median":-7.678791,"eighty":-0.761266,"marketCap":84681492},{"date":"2023-05-12","current":-0.354811,"twenty":-33.85347,"median":-7.423381,"eighty":-0.704662,"marketCap":80232787},{"date":"2023-05-19","current":-0.343537,"twenty":-33.645304,"median":-7.313254,"eighty":-0.541435,"marketCap":77683236},{"date":"2023-05-26","current":-0.360909,"twenty":-33.539667,"median":-6.964672,"eighty":-0.508812,"marketCap":81611625},{"date":"2023-06-02","current":-0.328465,"twenty":-33.483742,"median":-6.920799,"eighty":-0.472667,"marketCap":74275164},{"date":"2023-06-09","current":-0.339395,"twenty":-33.399854,"median":-6.591237,"eighty":-0.462628,"marketCap":76746667},{"date":"2023-06-16","current":-0.31535,"twenty":-33.399854,"median":-6.109253,"eighty":-0.461208,"marketCap":71309360},{"date":"2023-06-23","current":-0.295504,"twenty":-33.39364,"median":-5.923875,"eighty":-0.456113,"marketCap":66821632},{"date":"2023-06-30","current":-0.319779,"twenty":-33.368784,"median":-5.740775,"eighty":-0.450811,"marketCap":72310970},{"date":"2023-07-07","current":-0.287623,"twenty":-33.294217,"median":-5.510394,"eighty":-0.448985,"marketCap":65039548},{"date":"2023-07-14","current":-0.348023,"twenty":-32.728749,"median":-5.371858,"eighty":-0.444746,"marketCap":78697853},{"date":"2023-07-21","current":-0.33997,"twenty":-32.517476,"median":-5.129869,"eighty":-0.440448,"marketCap":76876746},{"date":"2023-07-28","current":-0.313566,"twenty":-32.436695,"median":-5.001319,"eighty":-0.433933,"marketCap":70906115},{"date":"2023-08-04","current":-0.31023,"twenty":-32.185031,"median":-4.895421,"eighty":-0.404915,"marketCap":70151657},{"date":"2023-08-11","current":-0.294641,"twenty":-31.914725,"median":-4.730175,"eighty":-0.39128,"marketCap":66626513},{"date":"2023-08-18","current":-0.336613,"twenty":-31.687917,"median":-4.54747,"eighty":-0.386987,"marketCap":62542029},{"date":"2023-08-25","current":-0.333953,"twenty":-31.58228,"median":-4.458811,"eighty":-0.384195,"marketCap":62047729},{"date":"2023-09-01","current":-0.31582,"twenty":-31.479751,"median":-4.433769,"eighty":-0.383231,"marketCap":58678680},{"date":"2023-09-08","current":-0.308049,"twenty":-31.215658,"median":-4.327139,"eighty":-0.381873,"marketCap":57234802},{"date":"2023-09-15","current":-0.329122,"twenty":-31.035455,"median":-4.258344,"eighty":-0.380946,"marketCap":61150183},{"date":"2023-09-22","current":-0.296007,"twenty":-30.827288,"median":-4.224102,"eighty":-0.379063,"marketCap":54997442},{"date":"2023-09-29","current":-0.281444,"twenty":-30.678154,"median":-4.141394,"eighty":-0.374308,"marketCap":52291796},{"date":"2023-10-06","current":-0.277944,"twenty":-30.544554,"median":-4.129355,"eighty":-0.371172,"marketCap":51641401},{"date":"2023-10-13","current":-0.25561,"twenty":-30.398527,"median":-4.113877,"eighty":-0.368029,"marketCap":47491878},{"date":"2023-10-20","current":-0.262541,"twenty":-30.066082,"median":-4.089799,"eighty":-0.36446,"marketCap":48779661},{"date":"2023-10-27","current":-0.262541,"twenty":-29.87345,"median":-4.072601,"eighty":-0.363883,"marketCap":48779661},{"date":"2023-11-03","current":-0.269542,"twenty":-29.842381,"median":-4.045083,"eighty":-0.36335,"marketCap":50080452},{"date":"2023-11-10","current":-0.244969,"twenty":-29.702568,"median":-4.024445,"eighty":-0.360219,"marketCap":45514676},{"date":"2023-11-17","current":-0.221986,"twenty":-29.640428,"median":-3.96253,"eighty":-0.356595,"marketCap":43732592},{"date":"2023-11-24","current":-0.244304,"twenty":-29.578289,"median":-3.879978,"eighty":-0.354777,"marketCap":48129265},{"date":"2023-12-01","current":-0.223703,"twenty":-29.35148,"median":-3.82834,"eighty":-0.352625,"marketCap":44070798},{"date":"2023-12-08","current":-0.20845,"twenty":-29.286235,"median":-3.796429,"eighty":-0.347729,"marketCap":41065965},{"date":"2023-12-15","current":-0.214921,"twenty":-29.171277,"median":-3.776787,"eighty":-0.345147,"marketCap":42340740},{"date":"2023-12-22","current":-0.225816,"twenty":-29.031464,"median":-3.639199,"eighty":-0.344195,"marketCap":44487045},{"date":"2023-12-29","current":-0.252887,"twenty":-28.941362,"median":-3.559261,"eighty":-0.343247,"marketCap":49820287},{"date":"2024-01-05","current":-0.253547,"twenty":-28.848153,"median":-3.536008,"eighty":-0.33997,"marketCap":49950366},{"date":"2024-01-12","current":-0.243643,"twenty":-28.506387,"median":-3.483638,"eighty":-0.337429,"marketCap":47999180},{"date":"2024-01-19","current":-0.316934,"twenty":-28.369681,"median":-3.465238,"eighty":-0.336501,"marketCap":62437958},{"date":"2024-01-26","current":-0.386264,"twenty":-28.310648,"median":-3.452972,"eighty":-0.336501,"marketCap":76096261},{"date":"2024-02-02","current":-0.387914,"twenty":-28.292006,"median":-3.364023,"eighty":-0.336906,"marketCap":76421459},{"date":"2024-02-09","current":-0.384943,"twenty":-28.189477,"median":-3.322747,"eighty":-0.337071,"marketCap":75836103},{"date":"2024-02-16","current":-0.385428,"twenty":-28.164621,"median":-3.268344,"eighty":-0.337362,"marketCap":75931711},{"date":"2024-02-23","current":-0.388905,"twenty":-28.164621,"median":-3.262844,"eighty":-0.338574,"marketCap":76616578},{"date":"2024-03-01","current":-0.393527,"twenty":-28.145979,"median":-3.250578,"eighty":-0.339372,"marketCap":77527131},{"date":"2024-03-08","current":-0.384943,"twenty":-28.12423,"median":-3.219912,"eighty":-0.339395,"marketCap":75836103},{"date":"2024-03-15","current":-0.411684,"twenty":-28.071412,"median":-3.219556,"eighty":-0.33974,"marketCap":81104306},{"date":"2024-03-22","current":-0.490441,"twenty":-28.01238,"median":-3.210713,"eighty":-0.341385,"marketCap":76551538},{"date":"2024-03-28","current":-0.46252,"twenty":-27.987524,"median":-3.183762,"eighty":-0.342619,"marketCap":72193434},{"date":"2024-04-05","current":-0.452103,"twenty":-27.940919,"median":-3.140181,"eighty":-0.343247,"marketCap":70567456},{"date":"2024-04-12","current":-0.460854,"twenty":-27.866352,"median":-3.084982,"eighty":-0.343721,"marketCap":71933277},{"date":"2024-04-19","current":-0.433769,"twenty":-27.83839,"median":-3.023651,"eighty":-0.344096,"marketCap":67705734},{"date":"2024-04-26","current":-0.433353,"twenty":-27.810427,"median":-2.989918,"eighty":-0.344583,"marketCap":67640695},{"date":"2024-05-03","current":-0.467521,"twenty":-27.697023,"median":-2.974585,"eighty":-0.345113,"marketCap":72973903},{"date":"2024-05-10","current":-0.467937,"twenty":-27.564977,"median":-2.950052,"eighty":-0.345147,"marketCap":73038942},{"date":"2024-05-17","current":-0.622329,"twenty":-27.434484,"median":-2.896224,"eighty":-0.345147,"marketCap":76746173},{"date":"2024-05-24","current":-0.592794,"twenty":-27.114467,"median":-2.845789,"eighty":-0.345423,"marketCap":73103982},{"date":"2024-05-31","current":-0.582246,"twenty":-26.667064,"median":-2.818189,"eighty":-0.345841,"marketCap":71803199},{"date":"2024-06-07","current":-0.562886,"twenty":-25.902752,"median":-2.753791,"eighty":-0.345994,"marketCap":69415613},{"date":"2024-06-14","current":-0.553767,"twenty":-25.67905,"median":-2.723125,"eighty":-0.346555,"marketCap":68291086},{"date":"2024-06-21","current":-0.52265,"twenty":-25.641767,"median":-2.680193,"eighty":-0.347729,"marketCap":64453777},{"date":"2024-06-28","current":-0.52265,"twenty":-25.616911,"median":-2.594329,"eighty":-0.348771,"marketCap":64453777},{"date":"2024-07-05","current":-0.538994,"twenty":-25.554772,"median":-2.023945,"eighty":-0.351763,"marketCap":66469340},{"date":"2024-07-12","current":-0.511575,"twenty":-25.244075,"median":-1.60689,"eighty":-0.352331,"marketCap":63087956},{"date":"2024-07-15","current":-0.670849,"twenty":-25.225433,"median":-1.600756,"eighty":-0.352383,"marketCap":82729773},{"date":"2024-08-02","current":-0.656609,"twenty":-25.206792,"median":-1.576223,"eighty":-0.352434,"marketCap":80973716},{"date":"2024-08-09","current":-0.617582,"twenty":-25.070086,"median":-1.502626,"eighty":-0.352603,"marketCap":76160821},{"date":"2024-08-16","current":-0.555881,"twenty":-24.905416,"median":-1.404495,"eighty":-0.352625,"marketCap":66469990},{"date":"2024-08-23","current":-0.679893,"twenty":-24.611458,"median":-1.204279,"eighty":-0.352694,"marketCap":81298912},{"date":"2024-08-30","current":-0.682341,"twenty":-24.259697,"median":-1.002123,"eighty":-0.353381,"marketCap":81591588},{"date":"2024-09-06","current":-0.769639,"twenty":-24.235787,"median":-0.912595,"eighty":-0.354333,"marketCap":92030368},{"date":"2024-09-13","current":-2.527027,"twenty":-24.187968,"median":-0.964579,"eighty":-0.354673,"marketCap":302171797},{"date":"2024-09-20","current":-3.195498,"twenty":-24.151016,"median":-1.166962,"eighty":-0.355085,"marketCap":382104888},{"date":"2024-09-27","current":-3.7182,"twenty":-24.035815,"median":-1.218719,"eighty":-0.356243,"marketCap":444607492},{"date":"2024-10-04","current":-2.844673,"twenty":-23.866273,"median":-1.404495,"eighty":-0.356511,"marketCap":340154649},{"date":"2024-10-11","current":-2.039136,"twenty":-23.761939,"median":-1.502626,"eighty":-0.356632,"marketCap":243831698},{"date":"2024-10-18","current":-2.146287,"twenty":-23.668473,"median":-1.576223,"eighty":-0.356987,"marketCap":256644406},{"date":"2024-10-25","current":-1.679608,"twenty":-23.529363,"median":-1.613023,"eighty":-0.358234,"marketCap":200840833},{"date":"2024-10-31","current":-1.864539,"twenty":-23.355473,"median":-1.679608,"eighty":-0.359898,"marketCap":222954137},{"date":"2024-11-08","current":-1.546893,"twenty":-23.181584,"median":-1.612865,"eighty":-0.360219,"marketCap":184971285},{"date":"2024-11-15","current":-2.556005,"twenty":-22.768598,"median":-1.677433,"eighty":-0.360843,"marketCap":192122113},{"date":"2024-11-22","current":-2.149684,"twenty":-22.13825,"median":-1.702453,"eighty":-0.360909,"marketCap":161580962},{"date":"2024-11-29","current":-2.336348,"twenty":-21.764388,"median":-1.77289,"eighty":-0.362106,"marketCap":175611619},{"date":"2024-12-06","current":-2.273837,"twenty":-21.627451,"median":-1.829185,"eighty":-0.362787,"marketCap":170912980},{"date":"2024-12-13","current":-1.86057,"twenty":-21.5905,"median":-1.868075,"eighty":-0.363257,"marketCap":139849758},{"date":"2024-12-20","current":-1.743362,"twenty":-21.540506,"median":-1.87161,"eighty":-0.363514,"marketCap":131039810},{"date":"2024-12-27","current":-1.857966,"twenty":-21.281846,"median":-1.87161,"eighty":-0.363752,"marketCap":139653981},{"date":"2025-01-03","current":-1.877066,"twenty":-21.060138,"median":-1.864539,"eighty":-0.363883,"marketCap":141089676},{"date":"2025-01-10","current":-1.910058,"twenty":-20.781915,"median":-1.864539,"eighty":-0.363883,"marketCap":143569514},{"date":"2025-01-17","current":-1.859702,"twenty":-19.940727,"median":-1.858834,"eighty":-0.363909,"marketCap":139784499},{"date":"2025-01-24","current":-2.094986,"twenty":-19.671199,"median":-1.84885,"eighty":-0.364015,"marketCap":157469653},{"date":"2025-01-31","current":-2.084568,"twenty":-19.138664,"median":-1.86057,"eighty":-0.364757,"marketCap":156686546},{"date":"2025-02-07","current":-2.03508,"twenty":-18.845226,"median":-1.868075,"eighty":-0.365799,"marketCap":152966791},{"date":"2025-02-14","current":-2.070677,"twenty":-18.801754,"median":-1.86057,"eighty":-0.36602,"marketCap":155642404},{"date":"2025-02-21","current":-2.084568,"twenty":-18.63656,"median":-1.87161,"eighty":-0.367474,"marketCap":156686546},{"date":"2025-02-28","current":-1.677378,"twenty":-18.299649,"median":-1.862554,"eighty":-0.368093,"marketCap":126080136},{"date":"2025-03-07","current":-1.68924,"twenty":-18.217052,"median":-1.857966,"eighty":-0.369359,"marketCap":125231771},{"date":"2025-03-14","current":-1.677796,"twenty":-18.032295,"median":-1.827825,"eighty":-0.369974,"marketCap":124383406},{"date":"2025-03-21","current":-1.735014,"twenty":-17.977955,"median":-1.826465,"eighty":-0.370053,"marketCap":128625232},{"date":"2025-03-28","current":-1.704204,"twenty":-17.775808,"median":-1.812032,"eighty":-0.371545,"marketCap":126341172},{"date":"2025-04-04","current":-1.46389,"twenty":-17.569315,"median":-1.789377,"eighty":-0.372545,"marketCap":108525500},{"date":"2025-04-11","current":-1.248224,"twenty":-17.460635,"median":-1.76116,"eighty":-0.37304,"marketCap":92537077},{"date":"2025-04-17","current":-1.346814,"twenty":-17.417162,"median":-1.749709,"eighty":-0.373783,"marketCap":99846071}],"updateTime":1745268625180}}}